Kenyans to Get Free HIV Prevention Jab

Kenya has become one of the first countries to introduce a new HIV prevention therapy.

The treatment will be available free of charge to eligible patients, according to the Country’s Health Ministry.

The drug Lenacapavir, known as LEN, is a long-acting injectable administered once every six months.

The drug is injected subcutaneously, just below the skin, in he lower abdomen or thighs.

According to health experts, Pregnant and breastfeeding mothers can also use he drug safely.

Kenya’s Health Minister Aden Duale said, the introduction of Lenacapavir as a milestone in prevention efforts, noting that 1.4 million Kenyans are living with HIV, with the highest burden among those aged 15 to 24.

“Many of our young people still face the risk of infection. This innovation gives us renewed strength in our national fight against HIV,” Duale, said adding that the drug will be free to those receiving it.

Some 12,000 doses are expected by April while an additional 25,000 doses from the United States government will strengthen early implementation.

The government said Lenacapavir has met all regulatory and procurement requirements under Kenyan law and health guidelines.

Lenacapavir is generally considered safe. Following the clinical trials, the United States Food and Drug Administration approved it for use in June 2025.

The World Health Organisation (WHO) endorsed its approval by releasing guidelines for its use at the 13th International Aids Society Conference held in Kigali, Rwanda, in July 2025.